Pharma stocks rise up to 6% on defensive buying
On September 21, pharmaceutical shares posted positive sentiment for a third straight day, with Mankind Pharma and Wockhardt among the top gainers; the sector rise is attributed to defensive buying, upcoming product launch pipelines, and regulatory approvals.
Shares of pharmaceutical companies traded with positive sentiment for a third straight day on September 21, with Mankind Pharma and Wockhardt leading gains. Apart from ongoing defensive buying in the sector, upcoming launch pipelines and regulatory approvals for new drugs are driving a structural shift in sentiment.